AWARD YEAR
2015
CATEGORY
Body
GOALS
Good Health & Well-being
KEYWORDS
Retinopathy of Prematurity, Preventable blindness in premature infants, World eye health
COUNTRY
India
DESIGNED BY
Forus Health is an innovative health care company that manufactures a range of affordable eye care equipments under the brand of 3nethra. 3nethra product suite detects critical eye ailments including cataract, glaucoma, diabetic retina, Retinopathy of Prematurity, serious retinal detachments, hemorrhages, AMD, optic nerve disorders, dry eye and refractive error measurements. Forus estimates to have touched over 1000000 lives till date with over 600 installations in 20 countries.
WEBSITE
http://www.forushealth.com/forus/3nethra-neo.html
3nethra neo – Retinopathy of Prematurity (ROP) screening device
Abnormal artery growth often blinds premature babies. 3nethra neo detects it in time for treatment.
Retinopathy of prematurity (ROP) is the most prevalent causes of blindness in premature babies. According to UN survey, 11.1% (~15M/year) of global live-births are premature. 60% of these are at risk for ROP. Even normal births have a 2% risk. Treatment — only possible within weeks of birth — requires diagnosis, traditionally with an indirect ophthalmoscope. Doctors with this diagnostic skill are few in the world, and fewer in India. A rural technician with a suitable retinal camera can transmit images to urban specialists, making universal diagnosis possible. But the device already available for this purpose costs USD110K.
3nethra neo addresses the primary cause why ROP isn’t yet a fully correctable disease: high cost of screening system. It is fast responsive, intuitive, ergonomic, light weight and is available at an affordable cost. Neo captures high quality, full color images of the pre-term eye with minimal discomfort to the baby and also identifies retinoblastoma and glaucoma
